Abstract Library

#4479 Bilateral adrenal masses associated with arterial hypertension with rare and unexpected definitive histopathological diagnosis: A case report

Introduction: During the clinical approach of bilateral adrenal masses, some imaging, biochemical and clinical guidelines are established to guide the diagnosis; however, only the histopathological result is what definitively establishes the diagnosis.

Conference:

Presenting Author: Rueda M

Authors: Rueda M, Cuellar A, Tapiero-Garcia M,

Keywords: adrenal gland, adrenal mass, Cystic lymphangioma, endothelial cyst, systemic arterial hypertension,

#4436 Application of novel wound materials in symptom management of patients with neuroendocrine tumours

Introduction: Neuroendocrine tumours can occur in multiple parts of the body, and management faces challenges.

Conference:

Presenting Author:

Authors: Liu G, Gu T, Tang Y, Xie W, Zhu Y,

Keywords: neuroendocrine tumour, novel wound materials, symptom management,

#4422 A case report of an undifferentiated neuroendocrine carcinoma with an unknown primary site

Introduction: In the situation where the primary lesion remains unknown, high-grade poorly differentiated neuroendocrine carcinoma typically shows extensive metastasis at the time of clinical visit. Common metastatic sites include the liver, bones, lungs and brain, and the prognosis is extremely poor.

Conference:

Presenting Author:

Authors: Lv J, Tang Y,

Keywords: poorly differentiated neuroendocrine carcinoma, unknown primary origin,

#4247 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia - A case report

Introduction: Idiopathic Diffuse Neuroendocrine Diffuse Neuroendocrine Hyperplasia is a rare, but increasingly recognized entity that primarily affects middle-aged and elderly women, Of available therapies, somatostatin analogs and mTOR are the most promising

Conference:

Presenting Author: Florez A

Authors: Florez A, Unigarro M, Fernandez J, Viola L, Perez G,

Keywords: neuroendocrine tumor, lung, idiopathic diffuse neuroendocrine hyperplasia, tumorlets,

#3952 Peptide Receptor Radionuclide Therapy (PRRT) in the management of patients with ectopic Cushing’s syndrome due to metastatic gastroenteropancreatic neuroendocrine neoplasia (GEPNEN): A single centre experience

Introduction: Metastatic GEPNEN can cause ectopic Cushing’s syndrome (ECS). ECS is highly morbid and often refractory to medical therapy. Bilateral adrenalectomy (BA) carries risk and long-term morbidity. Patients (pts) unsuitable for surgery have dismal outcomes. Peptide receptor radionuclide therapy (PRRT) is a rational option for hormone control in ECS caused by NEN with high somatostatin receptor (SSTR) expression yet detailed case series to guide its use are lacking.

Conference:

Presenting Author: Boehm E

Authors: Boehm E, Hung T, Akhurst T, Alipour R, Cardin A,

Keywords: GEPNEN, PRRT, Ectopic Cushing's Syndrome,